ALB and chronic kidney disease: A small pilot study conducted in Italy on a group of 27 patients with stage I-IV CKD revealed that the daily consumption of 40 mL of EVOO for 9 weeks was significant for the improvement of the eGFR (p-value 0.04) and serum concentration of albumin (p-value 0.021) and the reduction in the serum concentration of triglycerides (0.016) and uric acid (p-value 0.049) [50].